MENU
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

REGENXBIO (RGNX) Earnings Date & Reports

Regenxbio Inc is a biotechnology company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RGNX is expected to report earnings to fall 116.65% to 19 cents per share on March 03

REGENXBIO RGNX Stock Earnings Reports
Q4'25
Est.
$0.20
Q3'25
Beat
by $0.10
Q2'25
Missed
by $0.44
Q1'25
Missed
by $0.36
Q4'24
Beat
by $0.12
The last earnings report on November 06 showed earnings per share of -120 cents, beating the estimate of -129 cents. With 201.56K shares outstanding, the current market capitalization sits at 587.48M.
View a ticker or compare two or three
RGNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGNX showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com